Effects of DNA Origami‐Based Nanoagent Design on Apoptosis Induction in a Large 3D Cancer Spheroid Model
Small · 2025
DOI: 10.1002/smll.202502490 ↗Kurz gefasst
Fachartikel in der Zeitschrift Small, 2025. Verfasst von Johann M Weck und 6 weiteren Autor:innen. Beteiligte Einrichtung: Max Planck Institute of Biochemistry, Martinsried and Center for NanoScience (CeNS), Ludwig-Maximilians-University, Am Klopferspitz 18, 82152, Munich…. Hauptthemen laut MEDLINE: Spheroids, Cellular, Apoptosis, DNA, Nanostructures. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
DNA origami offers highly accurate control over shape and addressability on the nanoscale. This precise control makes it highly valuable in various fields, particularly precision nanotherapeutics. For cancer treatment, the extrinsic activation of programmed cell death by Fas receptor (FasR)/CD95‐based nanoagents is a promising, minimally invasive strategy. However, treating large, solid tumors poses challenges for the design of DNA origami‐based therapeutics, including drug distribution and altered cellular behavior. Here, these challenges are addressed by establishing design principles for nanoagents and testing them in a 3D cancer spheroid model. First, the ability of DNA origami nanostructures are assessed to penetrate large cancer spheroids, finding that penetration is influenced by the DNA origami size rather than its structural flexibility. Second, the capability of FasL‐DNA origami‐based nanoagents are evaluated to induce apoptosis in cancer spheroids, representing a more biologically relevant environment, compared to 2D studies. It is found that apoptosis induction is primarily determined by the FasL attachment strategy rather than the underlying DNA origami structure. The most effective nanoagents constructed in this study halted spheroid growth and eradicated all cancer cells within the spheroids. This study offers important insights into critical design considerations for DNA‐based therapeutics for complex cellular environments, advancing DNA origami nanotherapeutic development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Max Planck Institute of Biochemistry, Martinsried and Center for NanoScience (CeNS), Ludwig-Maximilians-University, Am Klopferspitz 18, 82152, Munich, Germany.
- Experimental Medical Physics, Heinrich-Heine University, Universitätsstraße 1, 40225, Düsseldorf, Germany.
ORCID-Profile: Amelie Heuer-Jungemann
Zitieren
APA
Weck, J. M., Nair, R., Kesici, M. Z., Shang, X., Gavrilović, S., Monzel, C., & Heuer-Jungemann, A. (2025). Effects of DNA Origami‐Based Nanoagent Design on Apoptosis Induction in a Large 3D Cancer Spheroid Model. Small. https://doi.org/10.1002/smll.202502490
Vancouver
Weck JM, Nair R, Kesici MZ, Shang X, Gavrilović S, Monzel C, et al. Effects of DNA Origami‐Based Nanoagent Design on Apoptosis Induction in a Large 3D Cancer Spheroid Model. Small. 2025. doi:10.1002/smll.202502490
BibTeX
@article{Weck2025,
author = {Weck, Johann M and Nair, Riya and Kesici, Merve-Z and Shang, Xiaoyue and Gavrilović, Svetozar and Monzel, Cornelia and Heuer-Jungemann, Amelie},
title = {Effects of DNA Origami‐Based Nanoagent Design on Apoptosis Induction in a Large 3D Cancer Spheroid Model},
journal = {Small},
year = {2025},
doi = {10.1002/smll.202502490}
}
EUVIMED